{"protocolSection":{"identificationModule":{"nctId":"NCT03668561","orgStudyIdInfo":{"id":"2017_01"},"secondaryIdInfos":[{"id":"2017-A02098-45","type":"OTHER","domain":"ID-RCB number, ANSM"}],"organization":{"fullName":"University Hospital, Lille","class":"OTHER"},"briefTitle":"the Effect of the CALIGALOC Orthosis on Standing and Walking of Hemiparetic Patients With Ankle Varus","officialTitle":"Evaluation of the Effect of the CALIGALOC Orthosis on Standing and Walking of Hemiparetic Patients With Ankle Varus","acronym":"CALIGALOC"},"statusModule":{"statusVerifiedDate":"2022-08","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2019-02-22","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2022-12","type":"ESTIMATED"},"completionDateStruct":{"date":"2022-12","type":"ESTIMATED"},"studyFirstSubmitDate":"2018-08-01","studyFirstSubmitQcDate":"2018-09-11","studyFirstPostDateStruct":{"date":"2018-09-12","type":"ACTUAL"},"lastUpdateSubmitDate":"2022-11-03","lastUpdatePostDateStruct":{"date":"2022-11-04","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"University Hospital, Lille","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"To assess the benefit of an anti-varus ankle foot orthosis (CALIGALOC, Bauerfeind) on gait and balance parameters in hemiparetic patients."},"conditionsModule":{"conditions":["Hemiparesis","Varus Deformity of Equine Carpus"],"keywords":["stroke","hemiplegia"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":30,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Treatment (CALIGALOC)","type":"EXPERIMENTAL","description":"Wearing of the Caligaloc orthosis","interventionNames":["Device: Caligaloc"]}],"interventions":[{"type":"DEVICE","name":"Caligaloc","description":"15 days of wearing of the Caligaloc orthosis","armGroupLabels":["Treatment (CALIGALOC)"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"10-meter walk test (in seconds)","description":"Maximum gait velocity, from a standing start","timeFrame":"comparison between baseline and 15 days"}],"secondaryOutcomes":[{"measure":"Assessment of gait temporospatial parameters by GaitRite®","description":"Specific temporal and spatial parameters of gait will be measured with the GaitRite gait evaluation system: gait cadence, hemiparetic step length, spatial asymmetry, swing and stance times.","timeFrame":"comparison between baseline and 15 days"},{"measure":"Posturographic analysis during static upright stance (center of pressure surface)","description":"Assessment of displacements of the center of pressure during quiet upright standing for 30s, using a Zebris platform","timeFrame":"comparison between baseline and 15 days"},{"measure":"Baropodometric analysis during gait","description":"Assessment of the paretic footprint during gait, using the Zebris platform","timeFrame":"comparison between baseline and 15 days"},{"measure":"Gait endurance (2-minute walk test)","description":"Assessment of maximum gait perimeter during a 2mwt","timeFrame":"comparison between baseline and 15 days"},{"measure":"Assessment of walking function","description":"Lower Limb Function assessment scale (LL-FAS, Allart et al. 2015) functional subscores","timeFrame":"comparison between baseline and 15 days"},{"measure":"Tolerability of the wearing of the Caligaloc orthosis assessed by visual analog scale","description":"visual analog scale (0=major discomfort - 10=excellent comfort)","timeFrame":"at 15 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Hemiparesis at \\> 3 months (whatever the etiology)\n* varus or equinovarus foot disturbing the stance phase of gait\n* Able to walk at least 10m, with or without assistive device\n\nExclusion Criteria:\n\n* unable to walk 10m\n* Botulinum toxin injection less than 3 months before inclusion\n* history of neurological or locomotor pathology in addition to the etiology of hemiparesis\n* Severe comprehension troubles\n* Pregnancy","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Etienne Allart, MD","role":"CONTACT","phone":"3 20 44 48 71","phoneExt":"+33","email":"etienne.allart@chru-lille.fr"}],"overallOfficials":[{"name":"Etienne Allart, MD","affiliation":"University Hospital, Lille","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Hôpital Swynghedau, CHI","status":"RECRUITING","city":"Lille","country":"France","contacts":[{"name":"Etienne Allart, MD,PhD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":50.63297,"lon":3.05858}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000010291","term":"Paresis"}],"ancestors":[{"id":"D000009461","term":"Neurologic Manifestations"},{"id":"D000009422","term":"Nervous System Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M12","name":"Congenital Abnormalities","relevance":"LOW"},{"id":"M9205","name":"Hemiplegia","relevance":"LOW"},{"id":"M20634","name":"Muscle Weakness","relevance":"LOW"},{"id":"M12894","name":"Paresis","asFound":"Hemiparesis","relevance":"HIGH"},{"id":"M12094","name":"Neurologic Manifestations","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC16","name":"Diseases and Abnormalities at or Before Birth"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC05","name":"Musculoskeletal Diseases"}]}},"hasResults":false}